Sensorion (ALSEN.PA) Stock Price

Sensorion Price

Euronext·CLOSED
0.27EUR+0.0080 (+3.03 %)
Market closed

Over the last 13 years Sensorion grew revenue by 164.9% annually, reaching 6.65 M EUR. For Sensorion, the net margin of -390.4% is down versus -381.7% a few years ago. The consensus 12-month price target for Sensorion is 2.04 EUR, about 661.2% above where the stock trades today. Of 13 analysts, 12 rate the stock a buy — an overall Buy consensus. The stock trades about 16% above its 52-week low.

Sensorion stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Sensorion over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Sensorion stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Sensorion's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Sensorion Stock Price History
DateSensorion Price
7/23/20260.27 EUR
7/22/20260.26 EUR
7/21/20260.26 EUR
7/20/20260.25 EUR
7/17/20260.26 EUR
7/16/20260.27 EUR
7/15/20260.27 EUR
7/14/20260.26 EUR
7/13/20260.26 EUR
7/10/20260.26 EUR
7/9/20260.26 EUR
7/8/20260.25 EUR
7/7/20260.25 EUR
7/6/20260.26 EUR
7/3/20260.26 EUR
7/2/20260.25 EUR
7/1/20260.25 EUR
6/30/20260.24 EUR
6/29/20260.23 EUR
6/26/20260.23 EUR
6/25/20260.23 EUR
6/24/20260.24 EUR
6/23/20260.25 EUR
6/22/20260.25 EUR
6/19/20260.26 EUR
6/18/20260.23 EUR
6/17/20260.25 EUR
6/16/20260.26 EUR
6/15/20260.26 EUR
6/12/20260.26 EUR
6/11/20260.28 EUR
6/10/20260.29 EUR
6/9/20260.36 EUR
6/8/20260.37 EUR
6/5/20260.38 EUR
6/4/20260.39 EUR
6/3/20260.39 EUR
6/2/20260.42 EUR
6/1/20260.43 EUR
5/29/20260.40 EUR
5/28/20260.39 EUR
5/27/20260.40 EUR
5/26/20260.40 EUR
5/25/20260.41 EUR
5/22/20260.40 EUR
5/21/20260.40 EUR
5/20/20260.40 EUR
5/19/20260.39 EUR
5/18/20260.39 EUR
5/15/20260.40 EUR
5/14/20260.42 EUR
5/13/20260.43 EUR
5/12/20260.45 EUR
5/11/20260.42 EUR
5/8/20260.43 EUR
5/7/20260.41 EUR
5/6/20260.40 EUR
5/5/20260.40 EUR
5/4/20260.39 EUR
4/30/20260.40 EUR
4/29/20260.37 EUR
4/28/20260.37 EUR
4/27/20260.37 EUR
4/24/20260.38 EUR
4/23/20260.38 EUR
4/22/20260.38 EUR
4/21/20260.37 EUR
4/20/20260.38 EUR
4/17/20260.40 EUR
4/16/20260.40 EUR
4/15/20260.40 EUR
4/14/20260.39 EUR
4/13/20260.37 EUR
4/10/20260.38 EUR
4/9/20260.39 EUR
4/8/20260.40 EUR
4/7/20260.39 EUR
4/2/20260.42 EUR
4/1/20260.43 EUR
3/31/20260.41 EUR
3/30/20260.35 EUR
3/27/20260.36 EUR
3/26/20260.38 EUR
3/25/20260.37 EUR
3/24/20260.37 EUR
3/23/20260.41 EUR
3/20/20260.62 EUR
3/19/20260.61 EUR
3/18/20260.58 EUR
3/17/20260.66 EUR
3/16/20260.68 EUR
3/13/20260.66 EUR
3/12/20260.70 EUR
3/11/20260.55 EUR
3/10/20260.47 EUR
3/9/20260.42 EUR
3/6/20260.40 EUR
3/5/20260.43 EUR
3/4/20260.38 EUR
3/3/20260.37 EUR
3/2/20260.40 EUR
2/27/20260.36 EUR
2/26/20260.35 EUR
2/25/20260.33 EUR
2/24/20260.33 EUR
2/23/20260.31 EUR
2/20/20260.32 EUR
2/19/20260.31 EUR
2/18/20260.31 EUR
2/17/20260.32 EUR
2/16/20260.33 EUR
2/13/20260.34 EUR
2/12/20260.34 EUR
2/11/20260.32 EUR
2/10/20260.34 EUR
2/9/20260.33 EUR
2/6/20260.31 EUR
2/5/20260.32 EUR
2/4/20260.34 EUR
2/3/20260.35 EUR
2/2/20260.34 EUR
1/30/20260.35 EUR
1/29/20260.38 EUR
1/28/20260.34 EUR
1/27/20260.28 EUR
1/26/20260.29 EUR
1/23/20260.30 EUR
1/22/20260.30 EUR
1/21/20260.29 EUR
1/20/20260.30 EUR
1/19/20260.31 EUR
1/16/20260.30 EUR
1/15/20260.29 EUR
1/14/20260.28 EUR
1/13/20260.31 EUR
1/12/20260.33 EUR
1/9/20260.33 EUR
1/8/20260.31 EUR
1/7/20260.32 EUR
1/6/20260.32 EUR
1/5/20260.32 EUR
1/2/20260.34 EUR
12/31/20250.34 EUR
12/30/20250.33 EUR
12/29/20250.33 EUR
12/24/20250.33 EUR
12/23/20250.32 EUR
12/22/20250.33 EUR
12/19/20250.33 EUR
12/18/20250.34 EUR
12/17/20250.34 EUR
12/16/20250.32 EUR
12/15/20250.32 EUR
12/12/20250.34 EUR
12/11/20250.35 EUR
12/10/20250.33 EUR
12/9/20250.31 EUR
12/8/20250.32 EUR
12/5/20250.31 EUR
12/4/20250.31 EUR
12/3/20250.31 EUR
12/2/20250.32 EUR
12/1/20250.32 EUR
11/28/20250.32 EUR
11/27/20250.31 EUR
11/26/20250.32 EUR
11/25/20250.33 EUR
11/24/20250.33 EUR
11/21/20250.33 EUR
11/20/20250.34 EUR
11/19/20250.36 EUR
11/18/20250.34 EUR
11/17/20250.35 EUR
11/14/20250.34 EUR
11/13/20250.35 EUR
11/12/20250.34 EUR
11/11/20250.34 EUR
11/10/20250.34 EUR
11/7/20250.35 EUR
11/6/20250.35 EUR
11/5/20250.34 EUR
11/4/20250.34 EUR
11/3/20250.35 EUR
10/31/20250.35 EUR
10/30/20250.34 EUR
10/29/20250.35 EUR
10/28/20250.35 EUR
10/27/20250.37 EUR
10/24/20250.37 EUR
10/23/20250.36 EUR
10/22/20250.34 EUR
10/21/20250.33 EUR
10/20/20250.35 EUR
10/17/20250.37 EUR
10/16/20250.37 EUR
10/15/20250.37 EUR
10/14/20250.36 EUR
10/13/20250.37 EUR
10/10/20250.36 EUR
10/9/20250.37 EUR
10/8/20250.37 EUR
10/7/20250.37 EUR
10/6/20250.40 EUR
10/3/20250.37 EUR
10/2/20250.37 EUR
10/1/20250.35 EUR
9/30/20250.34 EUR
9/29/20250.32 EUR
9/26/20250.32 EUR
9/25/20250.31 EUR
9/24/20250.31 EUR
9/23/20250.31 EUR
9/22/20250.31 EUR
9/19/20250.31 EUR
9/18/20250.30 EUR
9/17/20250.30 EUR
9/16/20250.30 EUR
9/15/20250.30 EUR
9/12/20250.31 EUR
9/11/20250.31 EUR
9/10/20250.30 EUR
9/9/20250.30 EUR
9/8/20250.30 EUR
9/5/20250.31 EUR
9/4/20250.31 EUR
9/3/20250.31 EUR
9/2/20250.31 EUR
9/1/20250.32 EUR
8/29/20250.32 EUR
8/28/20250.32 EUR
8/27/20250.32 EUR
8/26/20250.33 EUR
8/25/20250.34 EUR
8/22/20250.34 EUR
8/21/20250.33 EUR
8/20/20250.34 EUR
8/19/20250.35 EUR
8/18/20250.37 EUR
8/15/20250.34 EUR
8/14/20250.33 EUR
8/13/20250.32 EUR
8/12/20250.31 EUR
8/11/20250.31 EUR
8/8/20250.31 EUR
8/7/20250.32 EUR
8/6/20250.32 EUR
8/5/20250.32 EUR
8/4/20250.32 EUR
8/1/20250.33 EUR
7/31/20250.33 EUR
7/30/20250.35 EUR
7/29/20250.38 EUR
7/28/20250.36 EUR
7/25/20250.36 EUR
Access this data via the Eulerpool API
Get Free API Key

Sensorion Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
2.35 M EUR
-11.29 M EUR
-8.98 M EUR
Jan 1, 2021
4.26 M EUR
-19.35 M EUR
-15.14 M EUR
Jan 1, 2022
4.93 M EUR
-28.10 M EUR
-23.21 M EUR
Jan 1, 2023
5.70 M EUR
-22.31 M EUR
-22.06 M EUR
Jan 1, 2024
6.65 M EUR
-28.40 M EUR
-25.97 M EUR
Jan 1, 2025
0.00 EUR
-36.57 M EUR
-29.43 M EUR
Jan 1, 2026 (e)
21.86 M EUR
-23.26 M EUR
-8.52 M EUR
Jan 1, 2027 (e)
6.40 M EUR
-38.92 M EUR
-18.46 M EUR

Sensorion Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 25, 2026, 2:16 AM
 
REVENUEM EUR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM EUR
EBITM EUR
EBIT MARGIN%
NET INCOMEM EUR
NET INCOME GROWTH%
SHARESM
20152016201720182019202020212022202320242025e2026e2027e2028e2029e2030e
––––––––––12.0012.0012.00154.00184.00201.00
–––––––––––––1,183.3319.489.24
––––––––––33.3333.3333.332.602.171.99
4.004.004.004.004.002.004.004.004.004.004.004.004.004.004.004.00
-4.00-8.00-9.00-12.00-10.00-8.00-15.00-23.00-22.00-28.00-37.00-23.00-38.0050.00––
––––––––––-308.33-191.67-316.6732.47––
-4.00-8.00-9.00-12.00-12.00-8.00-15.00-23.00-22.00-25.00-26.00-13.00-13.0090.0065.0065.00
33.33100.0012.5033.33–-33.3387.5053.33-4.3513.644.00-50.00–-792.31-27.78–
4.056.427.2111.4118.6560.7679.6979.84133.42283.97283.97283.97283.97283.97283.97283.97
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Sensorion generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Sensorion retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Sensorion's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Sensorion has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Sensorion's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Sensorion stock margins

The Sensorion margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sensorion. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sensorion.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
82.35 %
-480.00 %
-381.71 %
Jan 1, 2021
87.96 %
-453.84 %
-355.01 %
Jan 1, 2022
84.38 %
-569.66 %
-470.42 %
Jan 1, 2023
66.48 %
-391.55 %
-387.21 %
Jan 1, 2024
100.00 %
-426.89 %
-390.38 %
Jan 1, 2025
100.00 %
- %
- %
Jan 1, 2026 (e)
100.00 %
-106.40 %
-38.97 %
Jan 1, 2027 (e)
100.00 %
-608.66 %
-288.63 %

Sensorion Stock Revenue, EBIT, Earnings per Share

The Sensorion earnings per share therefore indicates how much revenue Sensorion has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
0.03 EUR
-0.16 EUR
-0.12 EUR
Jan 1, 2021
0.05 EUR
-0.24 EUR
-0.19 EUR
Jan 1, 2022
0.06 EUR
-0.35 EUR
-0.29 EUR
Jan 1, 2023
0.03 EUR
-0.12 EUR
-0.12 EUR
Jan 1, 2024
0.02 EUR
-0.09 EUR
-0.09 EUR
Jan 1, 2025
0.00 EUR
-0.12 EUR
-0.10 EUR
Jan 1, 2026 (e)
0.08 EUR
-0.08 EUR
-0.03 EUR
Jan 1, 2027 (e)
0.02 EUR
-0.13 EUR
-0.07 EUR

Sensorion business model & stock analysis

The company Sensorion SA is a French biotechnology company that specializes in developing innovative therapies for hearing and balance disorders. It was founded in 2009 and is headquartered in Montpellier. Sensorion SA's business model is based on researching and developing new drugs that can be used to treat inner ear diseases. These diseases often have severe effects on the quality of life and social interaction of those affected and represent a significant unmet medical need. Sensorion SA aims to develop innovative and effective therapies to address this need. The company specializes in two main areas: hearing disorders and balance disorders. In the field of hearing disorders, Sensorion SA focuses on developing drugs to treat sensorineural hearing loss. These disorders can be caused by various factors such as aging, noise exposure, or genetic predisposition and affect the inner ear. Sensorion SA has a promising pipeline of drugs in clinical development based on different mechanisms of action. These drugs aim to protect the inner ear and restore hearing function. In the field of balance disorders, Sensorion SA focuses on developing new drugs to treat dizziness and vestibular disorders. These disorders can be caused by factors such as aging, medications, or neurological diseases and affect the balance system in the inner ear. Sensorion SA also has a promising pipeline of drugs in clinical development in this area. Sensorion SA's products are not yet available on the market as they are still in development and undergoing clinical trials. However, the company works closely with academic and industry partners to test and validate its drugs. The development of new drugs is a lengthy and costly process that can take many years. However, Sensorion SA is confident that its therapies have the potential to improve the lives of many people. Overall, Sensorion SA has a promising business model based on the development of innovative therapies for hearing and balance disorders. The company has a promising pipeline of drugs in clinical development and works closely with partners to test and validate its products. If successful, their drugs could have a significant impact on the lives of people suffering from these diseases.

Sensorion SWOT Analysis

Strengths

Sensorion SA possesses several strengths that contribute to its competitiveness and market position. These strengths include:

  • Strong technology portfolio with innovative solutions
  • Expertise in developing therapies for various hearing disorders
  • Collaboration with renowned research institutions and experts
  • Strong financial position and funding support
  • Robust intellectual property portfolio protecting its innovations

Weaknesses

Despite its strengths, Sensorion SA also faces certain weaknesses and areas of improvement, such as:

  • Relatively small market presence compared to larger competitors
  • Dependence on limited product pipeline
  • Challenges in gaining regulatory approvals for new therapies
  • Limited marketing and distribution capabilities
  • Highly focused on specific hearing disorders, limiting diversification

Opportunities

Sensorion SA can explore various opportunities to grow and expand its business, including:

  • Increasing global prevalence of hearing disorders
  • Expanding product pipeline to target additional indications
  • Strategic partnerships and collaborations to enhance R&D efforts
  • Exploring new markets and geographical expansion
  • Advancements in technology and healthcare supporting sensorineural therapies

Threats

While Sensorion SA strives for success, it faces certain threats and challenges that can hinder its progress, including:

  • Intense competition from larger pharmaceutical and biotech companies
  • Increasing regulatory requirements and complexities
  • Economic uncertainties impacting funding and market conditions
  • Emergence of alternative therapies and treatment options
  • Potential disruption from technological advancements outside its control

Sensorion Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Sensorion historical P/E ratio, EBIT multiple, and P/S ratio

Sensorion annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Sensorion shares outstanding

The number of shares of Sensorion was 300.92 M in 2025. This indicates how many shares Sensorion is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
72.71 M Stocks
Jan 1, 2021
79.88 M Stocks
Jan 1, 2022
79.86 M Stocks
Jan 1, 2023
187.06 M Stocks
Jan 1, 2024
303.56 M Stocks
Jan 1, 2025
300.92 M Stocks
Jan 1, 2026 (e)
300.92 M Stocks
Jan 1, 2027 (e)
300.92 M Stocks

Current Sensorion forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy92.31 % (12)
Hold7.69 % (1)
Sell0.00 % (0)
12M Price Target
2.04
Last Price
0.27
Currency
EUR
12M Return Potential
661.19 %
LTM Return
0 %

Sensorion Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
9/27/2021-0.13EUR-EUR2021 Q2

Sensorion shareholder structure

% Name
28.51738%
Invus
Invus
23.26049%
Redmile Group, LLC
Redmile Group, LLC
19.13499%
Sofinnova Partners
Sofinnova Partners
6.39276%
Fidelity Management & Research Company LLC
Fidelity Management & Research Company LLC
4.15514%
T. Rowe Price Associates, Inc.
T. Rowe Price Associates, Inc.
1.84865%
WuXi AppTec Co, Ltd.
WuXi AppTec Co, Ltd.

Sensorion Executives and Management Board

EF

Dr. Eric de La Fortelle

Independent Director - Represent of Health Opportunities · since 2019

Compensation33,000.00 EUR
AM

Mr. Amit Munshi

Independent Chairman of the Board · since 2025

NO

Mrs. Nawal Ouzren

Chief Executive Officer, Director

LD

Ms. Laurene Danon

Chief Financial Officer

BS

Mr. Bernd Schmidt

Chief Technical Officer

Sensorion Supply Chain

Sensorion Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
3 companies
#Name1M3M6M1Y2YTrend
1
WuXi AppTec Co H
Supplier
0.84
0.29
0.76
0.86
0.55
#Name1M3M6M1Y2YTrend
1
Cochlear
Supplier
0.89
0.14
0
0.50
0.17
2
3SBio
Supplier
-0.28
0.30
0.56
0.64
0.29

Frequently asked questions about Sensorion

Sensorion SA is a biopharmaceutical company specializing in the development of innovative therapies to address inner ear disorders. The company's business model revolves around the research, development, and commercialization of novel treatments for conditions such as vertigo and hearing loss. Sensorion SA aims to leverage its expertise in inner ear biology and drug development to create innovative therapies that can provide significant benefits to patients. With a focus on advancing its proprietary pipeline of drug candidates, Sensorion SA is dedicated to meeting the unmet medical needs in the field of inner ear disorders.

All fundamentals and in-depth analysis of Sensorion

Our stock analysis for Sensorion stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sensorion. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Sensorion Stock
Sensorion Revenue→
Sensorion Stock
Sensorion Net Income→
Sensorion Stock
Sensorion P/E→
Sensorion Stock
Sensorion P/S→
Sensorion Stock
Sensorion EBIT→
Sensorion Stock
Sensorion Dividend→
Sensorion Stock
Sensorion Directors Dealings→
Sensorion Stock
Sensorion Stocks→
Sensorion Stock
Sensorion Market capitalization→
Sensorion Stock
Sensorion Debt→
Sensorion Stock
Sensorion Liabilities→
Sensorion Stock
Sensorion Equity→
Sensorion Stock
Sensorion AAQS→
Sensorion Stock
Sensorion Employees→
Sensorion Stock
Sensorion ROE→
Sensorion Stock
Sensorion ROA→
Sensorion Stock
Sensorion ROCE→
Sensorion Stock
Sensorion News→
Sensorion Stock
Sensorion Analyst Price Targets→

Health Stocks

Sensus HealthcareSenseonics HoldingsSenti BiosciencesSensei BiotherapeuticsSenzaGenSenhwa BiosciencesSenzime AB (publ)SenestechSeoul Pharma CoSelvitaSeouleaguer CoSelvas HealthcareAll Stocks A–Z →